Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SH3RF1 antisense RNA 1 (SH3RF1-AS1) does not correspond to a recognized protein or established therapeutic target. Instead, it refers to a putative non-coding RNA (antisense RNA) that would, by naming convention, be transcribed from the antisense strand of the SH3RF1 gene locus. The SH3RF1 gene encodes a protein—E3 ubiquitin-protein ligase SH3RF1, also known as POSH—with roles in ubiquitination, JNK pathway scaffolding, neuronal migration, cell death, and immune signaling[1][3][4][5][6][7][8]. However, no structured information, functional studies, or recognized therapeutic roles for an antisense RNA specifically termed "SH3RF1-AS1" have been reported in gene/protein databases or the published literature. Because SH3RF1-AS1 is not listed in major databases and there is no evidence that it is a validated or characterized non-coding RNA, it should not be considered a standard therapeutic target or molecule for current biomedical research or drug discovery. For structured information about the protein-coding gene SH3RF1, refer to "SH3 domain containing ring finger 1 (SH3RF1)" and not to "SH3RF1-AS1"[1][3][4][5][6][7][8].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SH3RF1 antisense RNA 1 (SH3RF1-AS1).